What is the difference between IV infusion and direct injection? Can I choose only one?

Many patients receive only one route, and others combine both in the same visit. Your doctor recommends the route, or the combination, that fits your condition, your imaging and your goals, and you can always discuss whether a single route makes sense for you.

Choosing how stem cells are delivered is one of the most practical decisions in a regenerative treatment plan. The route determines where the cells go first, how many cells are used, how the procedure feels and how your stay is organized. This guide explains both routes in plain language, when each one is usually recommended at Stem Cell Mexico, and how to talk with your doctor about your options.

The cells are the same, the route is different

At Stem Cell Mexico, we use allogeneic mesenchymal stem cells (MSCs) derived from Wharton's jelly, the connective tissue inside donated umbilical cords from healthy full-term births. The same type of cell is used for direct injections and for IV infusions. What changes is the way the cells are delivered and the dose your doctor prescribes for that route.

Mesenchymal stem cells are known for their signaling activity. They release growth factors, cytokines and extracellular vesicles that help regulate inflammation and support the body's own repair processes. Researchers describe this as a "paracrine" effect: the cells act like messengers that influence the environment around them. A review in Frontiers in Immunology on MSC delivery explains that the route of administration shapes where the cells concentrate and how long they remain in a tissue, which is why route selection is part of every treatment plan.

What is direct injection?

A direct injection, also called a local or targeted application, places the cells exactly where the problem is located.

• Joints: knees, hips, shoulders, ankles, elbows, wrists and other joints are treated with ultrasound guidance, so the doctor can see the needle and the joint space in real time.
• Spine: for disc and facet problems, the doctor uses fluoroscopy, a real-time X-ray, to reach the target level precisely.
• Soft tissue: tendons and ligaments can be treated with ultrasound guidance as well.

Typical dose: in the treatment plans we send to patients, joint applications usually range from 20 to 40 million cells per treated area, depending on the joint, the severity of the damage and your imaging.

PRP is usually included: platelet-rich plasma (PRP), prepared from a small sample of your own blood, is included in our joint treatments because it adds growth factors that support the treated area.

What it feels like: the procedure is done with a local anesthetic and, when the doctor indicates it, sedation, so most patients feel little or no discomfort during the application. Some soreness or swelling in the treated joint during the following days is common and expected. For spine procedures, soreness can last a little longer, sometimes up to a few weeks.

What the evidence says: for knee osteoarthritis, a 2024 systematic review and meta-analysis of randomized controlled trials published in the Journal of Orthopaedic Translation reported improvements in pain and function with MSC injections compared with control treatments in many of the included trials. Results vary between patients and depend on factors such as the stage of arthritis, body weight and activity level.

What is IV infusion?

An intravenous (IV) infusion delivers the cells through a vein in your arm, in a process similar to receiving IV fluids. The infusion is given slowly while nurses and the medical team monitor your vital signs.

Typical dose: IV treatment plans usually range from 100 to 200 million cells, depending on the condition, your body weight and your medical history.

Why the IV route is used: once in the bloodstream, the cells circulate through the body and interact with immune and inflammatory pathways. For this reason, the IV route is commonly recommended for systemic goals, such as:

• Chronic inflammation and autoimmune conditions, such as rheumatoid arthritis.
• Metabolic and cardiovascular support, such as diabetes or circulation problems.
• Neurological conditions, such as Parkinson's disease, multiple sclerosis or recovery after a stroke.
• Healthy aging, fatigue and general recovery.

What it feels like: most patients feel nothing more than the small needle in the vein. The infusion itself is calm, and many patients read, rest or talk with the nurses while it is given.

What the evidence says about safety: a 2020 systematic review and meta-analysis in EClinicalMedicine, which pooled thousands of patients from clinical trials, reported that intravascular administration of mesenchymal stromal cells continues to appear safe, with transient fever as the most frequently associated event. An updated 2026 meta-analysis in Stem Cells Translational Medicine focused on umbilical cord-derived MSCs given intravascularly and reached consistent conclusions about safety. This is useful context, although every patient still needs an individual medical evaluation.

Side-by-side comparison

Can I choose only one route?

Yes. Many patients receive only one route. A patient with knee arthritis and no other health goals often receives a direct injection with PRP and nothing else. A patient interested in healthy aging, or managing an autoimmune condition, often receives only an IV infusion.

What matters is that the route matches the goal. If your main problem is pain in one knee, an IV infusion alone is not designed to concentrate cells in that knee. If your goal is to support systemic inflammation, a single joint injection is not designed to reach the whole body. Your doctor will explain the reasoning behind the recommendation, and you are free to ask questions and decide.

Why some patients combine both

Some patients choose to combine a direct injection with an IV infusion during the same visit. In the treatment proposals we send, this option is often offered to patients with joint degeneration who also want to support their overall inflammatory response. The idea is simple: the injection targets the damaged area, while the IV infusion supports the body as a whole. The combination is optional, and your advisor will quote it separately so you can compare both plans.

Other routes in selected cases

In selected neurological cases, the doctor may discuss other routes of administration after reviewing your medical reports and imaging. These options are evaluated case by case and are only proposed when the doctor considers them appropriate for your condition.

How the route affects your visit

Regardless of the route, the visit follows a similar structure:

1. Arrival day: laboratory tests, including tumor markers, your consent forms, and an in-person evaluation with the doctor and the stem cell specialist. If you need an MRI for a joint or the spine, it can be scheduled the same day.
2. Treatment day: the direct injection, the IV infusion or both, followed by a night at our facilities under nursing and medical monitoring.
3. Discharge: a final check, written aftercare instructions and transportation back to the San Diego area if it is part of your plan.

Direct injections usually come with specific activity guidance for the treated joint, such as avoiding high-impact exercise for some weeks. After an IV infusion, most patients return to light daily activities quickly.

How the doctor decides

The recommendation is based on:

• Your diagnosis and the area involved: a local problem tends to point to direct injection; a systemic goal tends to point to IV.
• Your imaging: MRI or X-ray findings help define which joints or spinal levels to treat.
• Your medical history and laboratory results: these confirm whether you are a good candidate and help define the dose.
• Your goals: pain relief in one area, overall wellness, or both.
• Your budget: combining routes increases the cost, and your advisor can show you both options.

Questions to ask your doctor

• Which route do you recommend for my condition, and why?
• How many cells will I receive with each route?
• Would combining both routes change my expected results?
• What should I avoid after the procedure?
• How will we follow up on my progress?

Bottom line

Direct injection and IV infusion use the same Wharton's jelly mesenchymal stem cells but deliver them in different ways. Direct injection targets a specific joint, disc or tissue, usually with 20 to 40 million cells per area plus PRP. IV infusion supports the whole body, usually with 100 to 200 million cells. You can receive one route or both, and the decision is made together with your doctor based on your condition, imaging, history and goals. Results vary from patient to patient, and no route guarantees a specific outcome. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your condition, goals and medical history.